Portside Wealth Group
WST icon

Portside Wealth Group’s West Pharmaceutical WST Stock Holding History

Portside Wealth Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$525K Sell
1,417
-115
-8% -$40.6K 0.06% 300
2026
Q2 		$550K Sell
1,532
-108
-7% -$33K 0.06% 284
2026
Q1 		$411K Sell
1,640
-365
-18% -$90.8K 0.06% 297
2025
Q4 		$552K Sell
2,005
-530
-21% -$145K 0.07% 234
2025
Q3 		$665K Buy
2,535
+22
+0.9% +$5.35K 0.09% 218
2025
Q2 		$550K Sell
2,513
-785
-24% -$168K 0.08% 230
2025
Q1 		$738K Buy
3,298
+203
+7% +$55.9K 0.12% 188
2024
Q4 		$1.01M Buy
3,095
+76
+3% +$23.9K 0.17% 131
2024
Q3 		$906K Buy
3,019
+204
+7% +$62.5K 0.15% 149
2024
Q2 		$927K Sell
2,815
-118
-4% -$41.7K 0.18% 130
2024
Q1 		$1.16M Buy
2,933
+258
+10% +$95.4K 0.21% 116
2023
Q4 		$942K Buy
2,675
+33
+1% +$11.7K 0.18% 130
2023
Q3 		$994K Sell
2,642
-55
-2% -$21.3K 0.19% 117
2023
Q2 		$1.03M Buy
+2,697
New +$963K 0.19% 121

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Portside Wealth Group's WST Position: Q3 2026 in Review

Portside Wealth Group reduced its West Pharmaceutical (WST) stake by 7.5% in Q3 2026, selling an estimated $40.6K and leaving 1,417 shares worth $525K. The position accounts for 0.06% of the portfolio, ranked #300.

Portside Wealth Group first reported a position in WST in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.16M in Q1 2024. 159 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Portside Wealth Group held 1,417 shares of West Pharmaceutical worth $525K as of Q3 2026.
  • Portside Wealth Group sold 115 West Pharmaceutical shares in Q3 2026, an estimated $40.6K.
  • West Pharmaceutical made up 0.06% of Portside Wealth Group's portfolio in Q3 2026, its #300 holding.
  • Portside Wealth Group first reported a position in West Pharmaceutical in Q2 2023 and has held it in 14 quarters since.
  • Portside Wealth Group's West Pharmaceutical position peaked at $1.16M in Q1 2024.
  • 159 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.